Oscar Health, Inc. (OSCR)

$15.54

-0.14

(-0.89%)▲

Market is closed - opens 7 PM, 18 Apr 2024

Insights on Oscar Health, Inc.

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 1.52B → 1.43B (in $), with an average decrease of 3.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -15.52M → -150.03M (in $), with an average decrease of 225.3% per quarter

  • Vs CI

    In the last 3 years, The Cigna Corp has given 37.0% return, outperforming this stock by 73.4%

Performance

  • $15.27
    $16.02
    $15.54
    downward going graph

    1.74%

    Downside

    Day's Volatility :4.68%

    Upside

    2.99%

    downward going graph
  • $4.72
    $18.55
    $15.54
    downward going graph

    69.63%

    Downside

    52 Weeks Volatility :74.56%

    Upside

    16.23%

    downward going graph

Returns

PeriodOscar Health, Inc.Sector (Financials)Index (Russel 2000)
3 Months
40.89%
6.3%
0.0%
6 Months
196.56%
19.8%
0.0%
1 Year
148.64%
19.0%
-1.5%
3 Years
-33.82%
12.1%
-21.8%

Highlights

Market Capitalization
3.6B
Book Value
$3.51
Earnings Per Share (EPS)
-1.22
Wall Street Target Price
17.17
Profit Margin
-4.62%
Operating Margin TTM
-10.2%
Return On Assets TTM
-3.62%
Return On Equity TTM
-31.86%
Revenue TTM
5.9B
Revenue Per Share TTM
26.44
Quarterly Revenue Growth YOY
41.8%
Gross Profit TTM
707.9M
EBITDA
-204.9M
Diluted Eps TTM
-1.22
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.16
EPS Estimate Next Year
0.39
EPS Estimate Current Quarter
-0.72
EPS Estimate Next Quarter
0.17

Analyst Recommendation

Buy
    54%Buy
    45%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Oscar Health, Inc.(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
7
Hold
5
6
6
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 10.49%

Current $15.54
Target $17.17

Company Financials

FY19Y/Y Change
Revenue
553.8M
-
Net Income
-261.2M
-
Net Profit Margin
-47.16%
-
FY20Y/Y Change
Revenue
589.6M
↑ 6.48%
Net Income
-406.8M
↑ 55.76%
Net Profit Margin
-69.0%
↓ 21.84%
FY21Y/Y Change
Revenue
1.9B
↑ 225.78%
Net Income
-571.4M
↑ 40.46%
Net Profit Margin
-29.75%
↑ 39.25%
FY22Y/Y Change
Revenue
4.1B
↑ 114.77%
Net Income
-609.6M
↑ 6.67%
Net Profit Margin
-14.77%
↑ 14.98%
FY23Y/Y Change
Revenue
5.9B
↑ 42.11%
Net Income
-270.7M
↓ 55.59%
Net Profit Margin
-4.62%
↑ 10.15%
Q3 FY22Q/Q Change
Revenue
40.1M
↓ 96.06%
Net Income
-193.5M
↑ 72.62%
Net Profit Margin
-482.83%
↓ 471.81%
Q4 FY22Q/Q Change
Revenue
1.0B
↑ 2488.58%
Net Income
-226.6M
↑ 17.06%
Net Profit Margin
-21.83%
↑ 461.0%
Q1 FY23Q/Q Change
Revenue
1.5B
↑ 41.49%
Net Income
-39.6M
↓ 82.51%
Net Profit Margin
-2.7%
↑ 19.13%
Q2 FY23Q/Q Change
Revenue
1.5B
↑ 3.68%
Net Income
-15.5M
↓ 60.82%
Net Profit Margin
-1.02%
↑ 1.68%
Q3 FY23Q/Q Change
Revenue
1.4B
↓ 5.4%
Net Income
-65.4M
↑ 321.16%
Net Profit Margin
-4.54%
↓ 3.52%
Q4 FY23Q/Q Change
Revenue
1.4B
↓ 0.58%
Net Income
-150.0M
↑ 129.41%
Net Profit Margin
-10.48%
↓ 5.94%
FY19Y/Y Change
Total Assets
1.3B
-
Total Liabilities
494.2M
-
FY20Y/Y Change
Total Assets
2.3B
↑ 68.69%
Total Liabilities
3.6B
↑ 621.92%
FY21Y/Y Change
Total Assets
3.3B
↑ 46.19%
Total Liabilities
440.0M
↓ 87.67%
FY22Y/Y Change
Total Assets
4.5B
↑ 36.28%
Total Liabilities
3.6B
↑ 725.92%
FY23Y/Y Change
Total Assets
3.4B
↓ 25.77%
Total Liabilities
2.6B
↓ 29.72%
Q3 FY22Q/Q Change
Total Assets
4.3B
↓ 9.31%
Total Liabilities
3.2B
↓ 7.95%
Q4 FY22Q/Q Change
Total Assets
4.5B
↑ 5.06%
Total Liabilities
3.6B
↑ 12.72%
Q1 FY23Q/Q Change
Total Assets
4.5B
↓ 0.96%
Total Liabilities
3.6B
↓ 2.28%
Q2 FY23Q/Q Change
Total Assets
4.6B
↑ 1.83%
Total Liabilities
3.6B
↑ 1.74%
Q3 FY23Q/Q Change
Total Assets
3.3B
↓ 26.63%
Total Liabilities
2.4B
↓ 32.8%
Q4 FY23Q/Q Change
Total Assets
3.4B
↑ 0.32%
Total Liabilities
2.6B
↑ 5.19%
FY19Y/Y Change
Operating Cash Flow
-165.4M
-
Investing Cash Flow
150.5M
-
Financing Cash Flow
-2.1M
-
FY20Y/Y Change
Operating Cash Flow
222.7M
↓ 234.69%
Investing Cash Flow
-344.7M
↓ 329.03%
Financing Cash Flow
611.7M
↓ 28967.72%
FY21Y/Y Change
Operating Cash Flow
-181.7M
↓ 181.6%
Investing Cash Flow
-774.5M
↑ 124.68%
Financing Cash Flow
1.2B
↑ 102.5%
FY22Y/Y Change
Operating Cash Flow
380.3M
↓ 309.28%
Investing Cash Flow
-226.5M
↓ 70.75%
Financing Cash Flow
301.1M
↓ 75.69%
Q3 FY22Q/Q Change
Operating Cash Flow
-548.4M
↓ 355.69%
Investing Cash Flow
298.8M
↑ 280.23%
Financing Cash Flow
423.0K
↓ 69.46%
Q4 FY22Q/Q Change
Operating Cash Flow
151.4M
↓ 127.61%
Investing Cash Flow
-706.7M
↓ 336.53%
Financing Cash Flow
527.0K
↑ 24.59%
Q1 FY23Q/Q Change
Operating Cash Flow
414.7M
↑ 173.93%
Investing Cash Flow
135.5M
↓ 119.18%
Financing Cash Flow
506.0K
↓ 3.98%
Q2 FY23Q/Q Change
Operating Cash Flow
165.5M
↓ 60.09%
Investing Cash Flow
43.9M
↓ 67.61%
Financing Cash Flow
2.6M
↑ 404.15%
Q3 FY23Q/Q Change
Operating Cash Flow
-1.1B
↓ 794.32%
Investing Cash Flow
225.3M
↑ 413.24%
Financing Cash Flow
2.3M
↓ 9.06%

Technicals Summary

Sell

Neutral

Buy

Oscar Health, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oscar Health, Inc.
Oscar Health, Inc.
12.36%
196.56%
148.64%
-33.82%
-55.34%
The Cigna Corp
The Cigna Corp
-1.86%
10.94%
33.27%
37.07%
132.27%
Centene Corp.
Centene Corp.
-6.52%
-1.34%
4.45%
10.13%
49.38%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
-1.65%
-10.65%
-5.05%
22.87%
116.0%
Cvs Health Corporation
Cvs Health Corporation
-11.56%
-3.5%
-9.9%
-9.44%
30.34%
Elevance Health, Inc
Elevance Health, Inc
-0.46%
8.45%
5.36%
34.06%
112.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oscar Health, Inc.
Oscar Health, Inc.
NA
NA
NA
-0.16
-0.32
-0.04
NA
3.51
The Cigna Corp
The Cigna Corp
19.96
19.96
0.89
28.43
0.12
0.04
0.02
158.03
Centene Corp.
Centene Corp.
14.69
14.69
0.68
6.77
0.11
0.04
NA
48.35
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
19.64
19.64
1.24
27.51
0.17
0.07
0.02
100.18
Cvs Health Corporation
Cvs Health Corporation
10.67
10.67
1.0
8.3
0.11
0.04
0.04
59.36
Elevance Health, Inc
Elevance Health, Inc
20.12
20.12
1.14
37.16
0.16
0.06
0.01
168.64
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oscar Health, Inc.
Oscar Health, Inc.
Buy
$3.6B
-55.34%
NA
-4.62%
The Cigna Corp
The Cigna Corp
Buy
$98.4B
132.27%
19.96
2.65%
Centene Corp.
Centene Corp.
Buy
$38.9B
49.38%
14.69
1.91%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$432.3B
116.0%
19.64
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$87.0B
30.34%
10.67
2.34%
Elevance Health, Inc
Elevance Health, Inc
Buy
$117.9B
112.41%
20.12
3.49%

Institutional Holdings

  • BlackRock Inc

    6.25%

  • Vanguard Group Inc

    6.20%

  • Dragoneer Investment Group, LLC

    5.54%

  • VK Services LLC

    2.98%

  • Southeastern Asset Management Inc

    2.49%

  • Formation8 GP, LLC

    2.26%

Corporate Announcements

  • Oscar Health, Inc. Earnings

    Oscar Health, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

healthcare is broken; we're trying to fix it. the oscar team is focused on utilizing technology, design and data to humanize healthcare. we're a group of technology and healthcare professionals who looked at the current state of the us healthcare system, got frustrated by the horrible consumer experience, and decided to do something big about it. backed by a renowned set of investors and advisors, we’ve set out to revolutionize healthcare.

Organization
Oscar Health, Inc.
Employees
2400
CEO
Mr. Joshua Kushner
Industry
Healthcare

Discover More

FAQs